Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Midazolam for Prevention of Emergence Delirium in Pediatric Ophthalmic Surgery
NCT04263844Phase 4Completed
- Sponsor
- Universitas Indonesia
- Start
- Jan 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in emergence delirium (ED) (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Incidence of Emergence Delirium. Started Jan 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT04263844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04263844.